BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ling Y, Li R, Zhong J, Zhao Y, Chen Z. Ixazomib-associated cardiovascular adverse events in multiple myeloma: a systematic review and meta-analysis. Drug Chem Toxicol 2020;:1-6. [PMID: 33108916 DOI: 10.1080/01480545.2020.1835945] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Balogun O, Jackson I, Oyenuga M, Oyenuga A, Etuk A, Jackson N. Burden of arrhythmias and predictors of mortality among multiple myeloma patients with arrhythmias. J Investig Med 2022:jim-2021-002321. [PMID: 35483747 DOI: 10.1136/jim-2021-002321] [Reference Citation Analysis]
2 Pozzi S, Bari A, Pecherstorfer M, Vallet S. Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma. Cancers (Basel) 2021;13:4978. [PMID: 34638462 DOI: 10.3390/cancers13194978] [Cited by in F6Publishing: 2] [Reference Citation Analysis]